- 22 July 2020
Sponsored
During this hour-long broadcast, Dr Kevin Fernando, Professor David Wheeler and Dr Amrit Lamba consider the recent license extension to Invokana® (canagliflozin) and how this could change the management of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) in primary care.